Michael Pham1, Roberta K Oka, John C Giacomini
1Division of Cardiovascular Medicine, Stanford University School of Medicine and Cardiology Section, VA Palo Alto Health Care System, Palo Alto, California, USA.
Statins, or 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors, may improve outcomes for heart failure patients. Early studies show reduced mortality, but larger trials are needed to confirm these benefits.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: